Product NDC: | 59762-3743 |
Proprietary Name: | clindamycin phosphate |
Non Proprietary Name: | clindamycin phosphate |
Active Ingredient(s): | 10 mg/g & nbsp; clindamycin phosphate |
Administration Route(s): | TOPICAL |
Dosage Form(s): | GEL |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 59762-3743 |
Labeler Name: | Greenstone LLC |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA050615 |
Marketing Category: | NDA AUTHORIZED GENERIC |
Start Marketing Date: | 19870107 |
Package NDC: | 59762-3743-1 |
Package Description: | 30 g in 1 TUBE (59762-3743-1) |
NDC Code | 59762-3743-1 |
Proprietary Name | clindamycin phosphate |
Package Description | 30 g in 1 TUBE (59762-3743-1) |
Product NDC | 59762-3743 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | clindamycin phosphate |
Dosage Form Name | GEL |
Route Name | TOPICAL |
Start Marketing Date | 19870107 |
Marketing Category Name | NDA AUTHORIZED GENERIC |
Labeler Name | Greenstone LLC |
Substance Name | CLINDAMYCIN PHOSPHATE |
Strength Number | 10 |
Strength Unit | mg/g |
Pharmaceutical Classes | Decreased Sebaceous Gland Activity [PE],Lincosamide Antibacterial [EPC],Lincosamides [Chemical/Ingredient] |